Latest News

Drug shows potential to delay onset or progression of Alzheimer's disease

An anti-atherosclerosis drug greatly reduced blood-brain barrier (BBB) leaks in animal models with diabetes and hypercholesterolemia and linked BBB permeability with amyloid peptide deposits at the site of early Alzheimer's pathology.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Neuroscientists identify new way several brain areas communicate

  • Air pollution linked to slower cognitive development in children

  • Creative genius driven by distraction

  • Republicans trust science -- except when it comes to health insurance and gay adoption

  • Alcohol screening, intervention for risky drinking: A guide for physicians

  • Anxious people more apt to make bad decisions amid uncertainty

  • Myelin-maker: How an FDA-approved drug boosts myelin synthesis

  • Vaccine skeptics aren't swayed by emotional scare tactics

  • Administering Sedatives for Patients Receiving General Anesthesia Questioned

  • Examination of prior authorization policies for antipsychotic prescribing to children

  •